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Intravascular proteolytic enzymes participate in a variety of linked reactions 
which are triggered in inflammatory and hemostatic events (1-4).  The mecha- 
nisms by which the action of these enzymes is limited to specific substrates, 
thereby sparing other proteins whose destruction would be deleterious to the 
organism,  are  not  understood.  Several  different plasma  proteins,  however, 
function as proteolytic enzyme inhibitors in in vitro studies,  suggesting that 
these naturally occurring inhibitors limit the digestive potential of intravascu- 
lar proteases (1, 5, 6). 
In this report, the localization of a2-macroglobulin (a2M) ~ to the endothelial 
surface of human blood  vessels  and  lymphatics has  been demonstrated.  By 
immunofluorescent-staining techniques, the a2M appears to form a thin, contin- 
uous lining on the luminal surface of endothelial cells. The immunologic speci- 
ficity of the immunofluorescent techniques used was established by the demon- 
stration  that  vessel  wall  staining  was  abolished  when  the  antiserum  was 
absorbed at equivalence with the purified a2M antigen. Other plasma proteins 
that were not detected on the endothelial cell lining included IgG, IgA, IgM, the 
third component of complement (C3), fibrinogen, al-antitrypsin, and antithrom- 
bin III. These observations suggest that the association between a2M and the 
vascular endothelium is specific. 
Prior studies have shown that the  a2M  modifies the enzymic activity of a 
number of proteases including enzymes which comprise the blood coagulation, 
fibrinolytic,  and kinin-generating systems  (1,  7-10).  The demonstration that 
a~M is localized at the interface between the vessel wall and the circulating 
blood suggests that this protein may play a vital role in protecting the vascular 
endothelium by modulating various protease-generating reactions which take 
place adjacent to the endothelial surface. 
Materials and Methods 
Purification  of Human  Plasma  a2M. Purification of human  plasma  a~M  was  performed  as 
described (11).  The final product formed a  single precipitin arc with a  mobility of an a2-globulin 
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after immunoelectrophoresis against rabbit anti-whole human serum.  Double-diffusion analysis 
(12) of the purified a2M demonstrated a reaction of identity with human serum using monovalent 
rabbit antihuman ~2M (RAH a~M).  Sodium dodecyl sulfate-acrylamide gel electrophoretic analy- 
sis of the purified a~M, after disulfide bond cleavage with dithiothreitol, demonstrated a  single 
protein band with an apparent mol wt of 185,000  as previously described for the subunit chain of 
~2M (7). 
Preparation of (~.2M  A ntisera.  Purified human plasma a2M was mixed with an equal volume of 
Freund's  complete  adjuvant  (Difco  Laboratories,  Detroit,  Mich.).  The  antigen  (200  ~g)  was 
injected intradermally into the shaved backs of white rabbits. A  second injection (200  ~g) was 
repeated  1 mo later.  At 6 wk high titers of antibody had developed. The antiserum was passed 
through an affinity column (13) containing insolubilized human IgG, since some antisera demon- 
strated trace reactivity with this protein. This procedure removed all antihuman IgG antibody. 
The antiserum was then absorbed with lyophilized human type A red blood cell stroma to remove 
anti-A antibodies, a potential contaminant in rabbit serum. The a~M antiserum was concentrated 
by ultrafiltration to approximately two times the protein concentration of the starting antiserum 
as determined by absorbancy at 280 nm. The concentrated antiserum produced one precipitin line 
by double-diffusion analysis against serial dilutions of the original  a2M antigen and of whole 
human serum. No precipitin reaction occurred between the antiserum and plasma depleted of a2M 
by  gel-filtration  chromatography  (Bio-Gel  A5m;  Bio-Rad  Laboratories,  Richmond,  Calif.).  A 
reaction of identity was observed by double-diffusion analysis between purified a~M and whole 
human serum using the concentrated rabbit antiserum toward azM (Fig.  1). 
Rabbit Antisera.  Rabbit antisera against the following human proteins were obtained from 
Behring Diagnostics, American Hoechst Corp., Woodbury, N. Y.: a2M, a~-antitrypsin, antithrom- 
bin III,  fl-lipoprotein, fibrinogen, IgG, IgA, IgM, and C3. 
Preparation of Fluoresceinated Goat Antibodies to Rabbit IgG.  IgG was isolated from pooled 
normal rabbit serum by fractionation with  (NH4)2SO4 and chromatography on DEAE-cellulose 
columns as previously described  (14).  Rabbit IgG  (1.0  rag) was  mixed with Freund's complete 
adjuvant and injected intramuscularly in a male goat. Injection was repeated after 1 mo and 2 wk 
later the goat was bled. Serum was harvested and tested for the presence of antibodies to rabbit 
IgG by immunoelectrophoresis in agarose gel.  By this technique, one precipitin arc was found 
between goat antisera to rabbit IgG and whole rabbit serum. The location of this precipitin arc 
was typical to that of IgG. This antibody was further purified by affinity chromatography using 
rabbit  IgG  coupled  to  Sepharose  4B  (13).  Goat  antirabbit IgG  (GARG)  was  eluted  from  the 
immunoabsorbent with 2 M potassium thiocyanate (15). 
GARG  was  coupled  to  crystalline  fluorescein  isothiocyanate  (FITC)  according  to  methods 
described by Goldstein et al., at a ratio of 8 mg FITC/g of protein (16).  Unconjugated fluorescein 
was removed by subsequent gel filtration chromatography using Sephadex G-25 (Pharmacia Fine 
Chemicals, Inc., Piscataway, N. J.). 
Source of Tissue Examined by Immunofluorescence Microscopy.  Tissues of adult humans were 
obtained at autopsy or immediately after surgical removal. Arteries with associated adventitial 
tissue, lymphatics, and veins were dissected from the mesenteric fat in specimens of colon or from 
fat and muscle in specimens of breast.  In general,  endothelial cells were best preserved in the 
surgical material. 
Preparation  of Tissues  for Immunofluorescence  Microscopy.  Blocks  of unfixed  tissue  were 
embedded in 7.5% gelatin and frozen according to the method of Burkholder et al.  (17).  Frozen 
sections were cut from these blocks and fixed in acetone for 10 min before treatment with serologic 
reagents.  Tissue sections on glass  slides were  washed for  15 min in phosphate-buffered saline 
(PBS), pH  7.4.  Excess PBS was wiped from the slides and a  drop of RAH  ~2M,  normal rabbit 
serum,  or RAH  a2M previously absorbed with purified  a2M was applied.  Rabbit antisera to a 
variety of other human plasma proteins were also tested on the tissue sections. The sections were 
incubated in a moist chamber at 37°C for 30 rain. They were then washed in three changes of PBS 
for 15 min each.  Excess PBS was wiped from the slides and a  drop of fluoresceinated (F)-GARG 
was applied to the section and incubated at 37°C for 30 rain. The slides were then washed in three 
changes of PBS for a  total of 15 min each and mounted in phosphate-buffered glycerol-Elvanol 
solution (18). 
Absorption Studies.  RAH  e~2M was diluted 1:2 with PBS and 0.2-ml portions pipetted into a 
series of Eppendorff centrifuge tubes. To these were added serial dilutions (0.2 ml) of purified CARL  G.  BECKER  AND  PETER  C.  HARPEL 
FIG.  1.  Double-diffusion analysis of rabbit antihuman a~M antiserum (Ab). The antibody 
is diffused against human serum (HS) and purified a2M. 
human  o~2M  ,  the  highest concentration  being 460  ~g/system.  The  tubes  were  incubated  with 
frequent shaking at 37°C for 12 h and then at 4°C for 18 h. The precipitate that was harvested by 
centrifugation was washed three times in PBS and its protein content determined by the Lowry 
procedure  (19).  The  supernate  was  examined for residual  antibody to  cx2M by double-diffusion 
analysis using purified human a~M as the antigen. By these methods the zones of antigen excess, 
equivalence, and antibody excess were determined. Portions of each supernate were used to treat 
tissue sections as described above in order to see if absorption of anti-a2M serum at equivalence 
with purified o~2M would inhibit immunofluorescent staining. These preparations were compared 
with tissue sections treated with unabsorbed antisera to asM at the same dilution as the supernate 
and with sections treated with pooled normal rabbit serum.  Other tissue sections were treated 
with rabbit antisera to human IgG, IgA, IgM, C3, fl-lipoprotein, fibrinogen, antithrombin III, and 
al-antitrypsin followed by the same F-GARG. 
Immunofluorescence Microscopy and Photomicrography.  Immunofluorescence microscopy and 
photomicrography were performed with a  Zeiss photomicroscope using an apo 40 objective (oil), a 
dark  field condenser  (1:2  to  1:4  NA),  an  HBO  200  W  mercury  vapor  lamp,  and  a  Zeiss  Kg-1 
absorption filter (Carl Zeiss, Inc.,  New York).  A  1 mm thick UG-2 exciter filter and a  Zeiss 41 
barrier filter were also used. Photomicrographs were made on 35 mm Anscochrome D-200 films (G 
A F  Corp., Photo & Repro Div., New York). 
Results 
A thin, continuous band of immunofluorescence was observed on the luminal 
surface of  endothelial cells when sections of human arteries (Figs. 2 and 4), veins 
(Fig.  3),  and  lymphatics  (Fig.  6) were treated  with  RAH  a2M followed by F- 
GARG.  The immunofluorescence  appeared to be localized to the glycocalyx of 
the  endothelial  cells  as  there  was  little,  if any,  staining  of the  cytoplasm. 
Basement membrane beneath endothelial cells, elastic lamina and myointimal 
and medial  smooth muscle cells of arteries,  smooth muscle cells of veins,  and 
connective tissue surrounding blood and lymphatic vessels were not immunoflu- 
orescent.  Elastic lamina and collagen were autofluorescent. 
When  sections  of human  liver  were  treated  with  these  reagents,  hepatic 
parenchymal cells were immunofluorescent as were the surfaces of endothelial 
cells lining arteries,  veins,  and sinusoids in the liver (Fig.  7). The intensity of 
immunofluorescence  of liver  parenchymal  cells  varied  between  tissue  speci- 4  o~2-MACROGLOBULIN  ON  HUMAN  VASCULAR  ENDOTHELIUM 
mens. The section shown represents the most intense immunofluorescence that 
we  observed.  When  sections  of human  kidney  were  treated  similarly,  the 
endothelial  surface of blood vessels was immunofluorescent but renal tubular 
epithelium was not stained. 
Immunofluorescent staining of endothelial cells (Fig. 5) and of the cytoplasm 
of hepatic parenchymal  cells was completely inhibited  by prior absorption  at 
equivalence of anti-a2M serum with purified a~M. Supernates from the zone of 
antigen excess did not stain the surface of endothelial cells, whereas supernates 
in  the  zone  of antibody  excess did.  These  absorption  experiments  are  sum- 
marized in Fig. 8. 
When sections of blood vessels were treated with rabbit antisera to human fl- 
lipoprotein followed by F-GARG, occasionally tiny dots of immunofluorescence, 
probably corresponding to vesicles, were present in endothelial cells. There was 
no continuous line of surface staining corresponding to the endothelial surface 
as observed with anti-a2M. 
Neither antiserum  against  antithrombin  III nor antiserum  against  al-anti- 
trypsin reacted with endothelial cells or any other components of blood vessel or 
lymphatic  vessel  walls.  Endothelial  cells  in  normal  blood  vessels  were  not 
stained when sections were treated with rabbit antisera toward IgG, IgA, IgM, 
C3, or fibrinogen followed by F-GARG. Neither endothelium nor hepatic paren- 
chymal cells were stained when sections were treated with pooled normal rabbit 
serum followed by F-GARG. 
Discussion 
In these experiments,  RAH  a2M stained the luminal  surface of endothelial 
cells in sections of arteries,  veins,  and lymphatics by the indirect immunoflu- 
orescent  technique.  This  antiserum  also  stained  hepatic  parenchymat  cells 
which have previously been shown to synthesize ~2M (20). The specificity of the 
antiserum  for  a2M  and  of the  immunohistochemical  localization  of c~2M was 
confirmed by immunodiffusion  and  immunoabsorption  studies.  The results  Of 
FIG.  2.  Frozen section of a medium sized branch of external mammary artery treated with 
RAH ~M followed by F-GARG. The luminal border of the endothelium is immunofluores- 
cent  (yellow green).  Underlying elastic laminae and collagen are  autofluorescent (blue 
white).  ×  500. 
FIG.  3.  Frozen section of an  intrahepatic vein treated with  RAH  a~M  followed by  F- 
GARG. The luminal border of the endothelium is immunofluorescent. Underlying connec- 
tive tissue is autofluorescent. ×  500. 
Fro.  4.  Frozen section of a  medium sized branch of mesenteric artery treated with RAH 
a2M followed by F-GARG. The luminal border of an endothelial cell is immunofluorescent. 
Underlying elastic laminae and collagen of the arterial wall are autofluorescent, x  500. 
FIG.  5.  Serial frozen section of artery shown in Fig. 4, treated with RAH a~M previously 
absorbed at equivalence with a2M, followed by F-GARG. Immunofluorescence of the endo- 
thelial border is abolished. Elastic laminae and collagen are autofluorescent, x  500. 
Fro.  6,  Section of lymphatic vessel adjacent to artery shown in Fig. 4, treated with RAH 
a2M followed by F-GARG. The endothelium is immunofluorescent. Surrounding connective 
tissue is autofluorescent. ×  500. 
FIG.  7.  Frozen  section of liver treated  with  RAH  a~M  followed by  F-GARG.  Hepatic 
parenchymal cells are immunofluorescent. The luminal borders of endothelial cells lining 
hepatic sinusoids are also immunofluorescent, x  500. 5 6  G2-MACROGLOBULIN  ON  HUMAN  VASCULAR  ENDOTHELIUM 
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FIG..  8.  Quantitative precipitin analysis of the a2M-anti-a2M reaction. Serial dilutions of 
purified human a2M (&) were added to a constant amount of rabbit antiserum to a~M. The 
resulting immune precipitates  (@) were quantitated by the Lowry procedure.  The super- 
nates were examined for free precipitating  (PPTNG) antibody by double diffusion using 
a2M as the antigen. The ability of the supernates to stain blood vessel wall endothelial cells 
and hepatic parenchymal cells was tested as detailed in the Materials and Methods.  IF, 
immunofluorescence. 
these studies indicate that a2M is present on the luminal surface of endothelial 
cells of human blood vessels. 
Other plasma  proteins,  some of which  have  comparable molecular weights 
and plasma  concentrations  to  a2M were not demonstrable  on endothelial  cell 
surfaces. The plasma concentration of a2M and the other major plasma protease 
inhibitor,  arantitrypsin,  are similar,  however, the molar ratio in plasma of a~- 
antitrypsin  to  a2M  is  approximately  12  to  1  (1).  Thus,  the  absence  of  a,- 
antitrypsin on the vessel wall further underlines the apparent specificity of the 
presence of a2M on the endothelial cell surface. It seems likely, therefore,  that 
a2M is associated with the endothelial surface in a specific manner and not as a 
result of passive absorption. 
Recently, Mosher and Wing  (21) reported synthesis and secretion of a2M by 
cultured human  WI-38 fibroblasts. In the present study no immunofluorescent 
staining of fibroblasts in the adventitia of blood vessels from adult humans was 
observed. These disparate results may be due to differences between proliferat- 
ing fibroblasts in tissue culture and fibroblasts in normal connective tissue. 
Factor VIII antigen  is synthesized by endothelial cells (22) and is stained by 
specific antisera in a granular pattern that appears to be localized to the cyto- 
plasm of these cells  (23). In contrast,  antibodies to  a2M stain  the endothelial 
surface in a  linear pattern  without staining endothelial  cell cytoplasm.  These 
findings suggest that  a2M may not be synthesized by endothelial cells. On the 
other hand,  B lymphocytes, which have been reported to possess a2M on their CARL  G.  BECKER  AND  PETER  C.  HARPEL 
surface  (24), may  synthesize this  protein  as  well  (25). a2M  has  also  been 
identified in human platelet membrane and granule fractions, but not in the 
cytoplasm  (26). The  finding,  as  reported  in  the  present  study,  of  a~M  on 
endothelial cell surfaces extends the spectrum of proteins which are shared by 
both platelets and endothelial cells.  Thus,  both contain, in addition to  a2M, 
immunochemically similar smooth muscle actomyosin (27), as well as signifi- 
cant amounts of factor VIII antigen (28). 
In  conclusion,  this  study establishes that  a2M  is  located at  the  interface 
between  the  blood  and  vessel  wall.  Given  the  broad  specificity of  a~M  in 
inhibiting proteases it is likely that this protein serves as a bulwark in protect- 
ing the endothelium from a variety of potentially injurious plasma and cellular 
enzymes which are released in the circulation during inflammatory  and hemo- 
static  events.  In  addition to this protective function, membrane-associated 
a2M may also modulate proteolytic reactions which occur on the surface of 
lymphocytes, platelets, and endothelial cells. 
Summary 
a2-Macroglobulin (a2M) has been identified on the luminal surface of endothe- 
lial cells in sections of normal human arteries, veins, and lymphatics by the 
indirect immunofluorescent  technique. The specificity of  the immunofluorescent 
reaction was confirmed by immunoabsorption studies. Prior absorption of the 
anti-a2M antiserum by purified a2M at equivalence completely inhibited endo- 
thelial surface as well as hepatic parenchymal cell staining. Endothelial cells in 
blood vessels were not stained when sections were treated with rabbit antisera 
toward a~-antitrypsin, antithrombin III, IgG, IgA, IgM, C3, or fibrinogen. The 
location of a2M  at the surface of the vessel wall suggests that this protease 
inhibitor may protect the vascular endothelium from potentially injurious intra- 
vascular proteases. 
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